Xeris Biopharma Holdings annual free cash flow
2020
2021
2022
2023
2024
2025
Xeris Biopharma Holdings Free Cash Flow (FCF) History (XERS)
Xeris Biopharma Holdings reported $27.9M in free cash flow for fiscal 2025, an increase of $65.8M from the previous fiscal year, with a free cash flow margin of 9.57%.
View full Xeris Biopharma Holdings company overviewXeris Biopharma Holdings free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $27.9M | $65.8M | — | +9.57% |
| 2024 | 2024-12-31 | −$37.8M | $11.4M | — | −18.64% |
| 2023 | 2023-12-31 | −$49.3M | $54.1M | — | −30.07% |
| 2022 | 2022-12-31 | −$103.4M | −$6.8M | — | −93.80% |
| 2021 | 2021-12-31 | −$96.6M | −$15.7M | — | −194.84% |
| 2020 | 2020-12-31 | −$80.9M | — | — | −401.56% |
Xeris Biopharma Holdings quarterly free cash flow
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $8.1M | $8.2M | — | +8.74% |
| Q1 2026 | 2026-03-31 | $9.5M | — | — | +11.48% |
| Q4 2025 | 2025-12-31 | $19.7M | — | — | +22.97% |
| Q3 2025 | 2025-09-30 | $18.4M | — | — | +24.69% |
| Q2 2025 | 2025-06-30 | −$97,000 | — | — | −0.14% |
Xeris Biopharma Holdings free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$80.9M to $27.9M, a net increase of $108.9M. Xeris Biopharma Holdings's latest reported quarter, Q2 2026, generated $8.1M in free cash flow, an increase of $8.2M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Xeris Biopharma Holdings source filings ↗